Utama › Neoplasma Mieloproliferatif
Kajian klinikal Neoplasma Mieloproliferatif sedang mengambil peserta di AS
50 kajian untuk Neoplasma Mieloproliferatif sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX16 kajian
- New York City, NY15 kajian
- Boston, MA14 kajian
- Milwaukee, WI10 kajian
- Miami, FL10 kajian
- Chicago, IL9 kajian
- Durham, NC9 kajian
- Baldwin Park, CA9 kajian
- Seattle, WA9 kajian
- Salt Lake City, UT8 kajian
- Cleveland, OH8 kajian
- Birmingham, AL8 kajian
- Tampa, FL8 kajian
- Columbus, OH8 kajian
- Atlanta, GA8 kajian
- St. Louis, MO8 kajian
- Philadelphia, PA8 kajian
- Portland, OR8 kajian
- Baltimore, MD7 kajian
- Los Angeles, CA7 kajian
- Mountain View, CA7 kajian
- Kansas City, MO7 kajian
- Winston-Salem, NC7 kajian
- Nashville, TN6 kajian
- Charlotte, NC6 kajian
- Irvine, CA6 kajian
- Jacksonville, FL6 kajian
- Ann Arbor, MI6 kajian
- Phoenix, AZ6 kajian
- Sacramento, CA5 kajian
- Washington, DC5 kajian
- Edison, NJ5 kajian
- Omaha, NE5 kajian
- San Francisco, CA5 kajian
- Charlottesville, VA5 kajian
- Rochester, MN5 kajian
- Pittsburgh, PA5 kajian
- Minneapolis, MN5 kajian
- The Bronx, NY4 kajian
- New Haven, CT4 kajian
Mengikut negeri
- Alabama8 kajian
- Arizona8 kajian
- Arkansas4 kajian
- California17 kajian
- Colorado6 kajian
- Connecticut5 kajian
- Florida13 kajian
- Georgia10 kajian
- Hawaii3 kajian
- Idaho4 kajian
- Illinois9 kajian
- Indiana4 kajian
- Iowa4 kajian
- Kansas6 kajian
- Kentucky3 kajian
- Louisiana4 kajian
- Maine4 kajian
- Maryland8 kajian
- Massachusetts15 kajian
- Michigan8 kajian
- Minnesota8 kajian
- Mississippi4 kajian
- Missouri8 kajian
- Montana3 kajian
- Nebraska5 kajian
- Nevada3 kajian
- New Jersey5 kajian
- New Mexico4 kajian
- New York15 kajian
- North Carolina13 kajian
- Ohio11 kajian
- Oklahoma5 kajian
- Oregon8 kajian
- Pennsylvania10 kajian
- Rhode Island4 kajian
- South Carolina5 kajian
- Tennessee8 kajian
- Texas18 kajian
- Utah8 kajian
- Vermont3 kajian
- Virginia6 kajian
- Washington9 kajian
- Wisconsin10 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Mengambil pesertaFasa 1/2
Umur 12 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06303193A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07469891Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06131801A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06661915MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05564390Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05320198Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Mengambil pesertaFasa 2
Umur 18 hingga 59 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT05554406Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Mengambil pesertaFasa 1
Umur 1 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT03630991Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT04282187(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04996875Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT03471260Cord Blood Transplant in Adults With Blood Cancers
Mengambil pesertaFasa 2
Umur 21 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05884333Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06291987Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT06523556CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04493164Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Mengambil peserta
Umur 19 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT04898790Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07565220A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07008118Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07249840A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07020533Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT07441694Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Mengambil pesertaFasa 2
6 Months – 65 Years · Semua jantina · Dikemas kini 22 Jul 2026 · NCT06013423Evaluation of the Pathobiology of CALR-mutated MPN Cells
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT06480591Allo HSCT Using RIC and PTCy for Hematological Diseases
Mengambil pesertaFasa 2
Sehingga umur 75 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT05805605Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.